These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12846369)
1. Second primary breast and thyroid cancers (Israel). Sadetzki S; Calderon-Margalit R; Peretz C; Novikov I; Barchana M; Papa MZ Cancer Causes Control; 2003 May; 14(4):367-75. PubMed ID: 12846369 [TBL] [Abstract][Full Text] [Related]
2. Trends of Second Primary Malignancy in Patients with Thyroid Cancer: A Population-Based Cohort Study in Israel. Izkhakov E; Barchana M; Liphshitz I; Silverman BG; Stern N; Keinan-Boker L Thyroid; 2017 Jun; 27(6):793-801. PubMed ID: 28338430 [TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2013: Multiple tumours. AIRTUM Working Group Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384 [TBL] [Abstract][Full Text] [Related]
4. A Possible Association Between Thyroid Cancer and Breast Cancer. An JH; Hwangbo Y; Ahn HY; Keam B; Lee KE; Han W; Park DJ; Park IA; Noh DY; Youn YK; Cho BY; Im SA; Park YJ Thyroid; 2015 Dec; 25(12):1330-8. PubMed ID: 26442580 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database. Li S; Yang J; Shen Y; Zhao X; Zhang L; Wang B; Li P; Wang Y; Yi M; Yang J BMC Public Health; 2019 Nov; 19(1):1592. PubMed ID: 31783815 [TBL] [Abstract][Full Text] [Related]
6. Cancer incidence in Israeli Jewish survivors of World War II. Keinan-Boker L; Vin-Raviv N; Liphshitz I; Linn S; Barchana M J Natl Cancer Inst; 2009 Nov; 101(21):1489-500. PubMed ID: 19861305 [TBL] [Abstract][Full Text] [Related]
7. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer. Zhang L; Wu Y; Liu F; Fu L; Tong Z Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440 [TBL] [Abstract][Full Text] [Related]
8. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up. Tadmor T; Liphshitz I; Silverman B; Polliack A Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496 [TBL] [Abstract][Full Text] [Related]
9. Risk of second primary malignancies in women with papillary thyroid cancer. Canchola AJ; Horn-Ross PL; Purdie DM Am J Epidemiol; 2006 Mar; 163(6):521-7. PubMed ID: 16421240 [TBL] [Abstract][Full Text] [Related]
10. Lower Cancer Rates Among Druze Compared to Arab and Jewish Populations in Israel, 1999-2009. Atzmon I; Linn S; Portnov BA; Richter E; Keinan-Boker L J Relig Health; 2017 Jun; 56(3):741-754. PubMed ID: 25516295 [TBL] [Abstract][Full Text] [Related]
11. Second primary cancers following breast cancer in the Japanese female population. Tanaka H; Tsukuma H; Koyama H; Kinoshita Y; Kinoshita N; Oshima A Jpn J Cancer Res; 2001 Jan; 92(1):1-8. PubMed ID: 11173537 [TBL] [Abstract][Full Text] [Related]
12. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada. MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718 [TBL] [Abstract][Full Text] [Related]
13. Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain). Molina-Montes E; Pollán M; Payer T; Molina E; Dávila-Arias C; Sánchez MJ Gynecol Oncol; 2013 Aug; 130(2):340-5. PubMed ID: 23648471 [TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures--Report 2015: The burden of rare cancers in Italy. ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748 [TBL] [Abstract][Full Text] [Related]
15. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice. Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009 [TBL] [Abstract][Full Text] [Related]
16. Time trends of incidence rates of thyroid cancer in Israel: what might explain the sharp increase. Lubina A; Cohen O; Barchana M; Liphshiz I; Vered I; Sadetzki S; Karasik A Thyroid; 2006 Oct; 16(10):1033-40. PubMed ID: 17042690 [TBL] [Abstract][Full Text] [Related]
17. Multiple primary malignant neoplasms in breast cancer patients in Israel. Schenker JG; Levinsky R; Ohel G Cancer; 1984 Jul; 54(1):145-50. PubMed ID: 6722740 [TBL] [Abstract][Full Text] [Related]
18. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271 [TBL] [Abstract][Full Text] [Related]
19. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study. Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627 [TBL] [Abstract][Full Text] [Related]
20. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors. Calip GS; Law EH; Ko NY Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]